Home / Inspections / 1014707

FDA Inspection 1014707 — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC — FEI 3001833549

The FDA completed an inspection of Fresenius Kabi USA, LLC on March 30, 2017 in Grand Island, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 30, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Grand Island, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1220482 (VAI Fri Oct 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1216357 (NAI Wed Aug 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1099323 (VAI Mon Aug 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1002820 (VAI Wed Feb 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 962308 (VAI Thu Feb 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources